B · Normal
[Anthropic joins hands with six institutions including Bristol-Myers Squibb to launch AI drug discovery and layout of rare disease treatments] On October 28th, Anthropic announced that its life sciences team has established in-depth research cooperation with six new drug R&D institutions including Bristol-Myers Squibb and Generate Biomedicines, and launched independent drug discovery projects. The first direction is rare childhood muscular dystrophy, with Claude responsible for most of the scientific and operational work.
Comments